Back to matchesWe found a matchYour institution may have access to this item. Find your institution then sign in to continue.TitleArtesunate, a new antimalarial clinical drug, exhibits potent anti‐AML activity by targeting the ROS/Bim and TFRC/Fe<sup>2+</sup> pathways.AuthorsLiu, Yi; Li, Han; Luo, Zhihong; Yu, You; Yang, Jingzhao; Zhang, Min; Law, Betty Yuen Kwan; Huang, Zan; Li, WenhuaPublicationBritish Journal of Pharmacology, 2023, Vol 180, Issue 6, p701ISSN0007-1188Publication typeArticleDOI10.1111/bph.15986